Literature DB >> 13411122

Adenoviruses as etiologic agents in conjunctivitis and keratoconjunctivitis.

R J HUEBNER, W P ROWE.   

Abstract

Entities:  

Keywords:  CONJUNCTIVITIS/etiology and pathogenesis; KERATOCONJUNCTIVITIS/etiology and pathogenesis; VIRUS DISEASES

Mesh：

Year:  1957        PMID： 13411122     DOI： 10.1016/0002-9394(57)91470-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  8 in total

1.  [Adenovirus infections in children].

Authors:  C CHANY
Journal:  Arch Gesamte Virusforsch       Date:  1963

2.  Newer aspects of adenovirus infections.

Authors:  H S GINSBERG
Journal:  Am J Public Health Nations Health       Date:  1959-11

Review 3.  Adenovirus keratoconjunctivitis.

Authors: 
Journal:  Br J Ophthalmol       Date:  1977-02       Impact factor: 4.638

4.  Specialty conference: potpourri of adenoviral infections.

Authors:  J D Connor; R M Buchta; F DeGenaro; M A Fletcher; W L Nyhan
Journal:  West J Med       Date:  1974-01

5.  An outbreak of adenovirus keratoconjunctivitis in bristol.

Authors:  A B Tullo; P G Higgins
Journal:  Br J Ophthalmol       Date:  1979-09       Impact factor: 4.638

6.  Adenovirus serotypes isolated from ocular infections in London.

Authors:  S Darougar; P Walpita; U Thaker; N Viswalingam; L Gardner; D A McSwiggan
Journal:  Br J Ophthalmol       Date:  1983-02       Impact factor: 4.638

7.  Latent species C adenoviruses in human tonsil tissues.

Authors:  C T Garnett; G Talekar; J A Mahr; W Huang; Y Zhang; D A Ornelles; L R Gooding
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

8.  Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10.

Authors:  Emily A Bates; James A Davies; Jana Váňová; Davor Nestić; Valerie S Meniel; Sarah Koushyar; Tabitha G Cunliffe; Rosie M Mundy; Elise Moses; Hanni K Uusi-Kerttula; Alexander T Baker; David K Cole; Dragomira Majhen; Pierre J Rizkallah; Toby Phesse; John D Chester; Alan L Parker
Journal:  Mol Ther Oncolytics       Date:  2022-03-16       Impact factor: 7.200
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.